Table of Contents
Global Perspectives on SFA Treatment
Experts from around the world describe the current interventional climate in their respective regions.
The Evolution of SFA Care: The DCB Paradigm Shift
An in-depth look at how the science and clinical use of the first FDA-approved drug-coated balloon, LUTONIX® 035, continues to advance the treatment of PAD.
Sponsored by Bard Peripheral Vascular, Inc.
In This Issue
Chief Medical Editors' Page
Cover Focus: Global Perspectives On Sfa Treatment
European Featured Technology
Coding & Reimbursement
August 2015 Supplement